ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM)

CUSIP: G6333L101

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / Stock
Total 13F shares
6,298,907
Share change
-47,404
Total reported value
$31,557,000
Price per share
$5.01
Number of holders
21
Value change
-$268,230
Number of buys
3
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP G6333L101?
CUSIP G6333L101 identifies ITRM - ITERUM THERAPEUTICS PLC SHS NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) as of Q4 2018

As of 31 Dec 2018, ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,298,907 shares. The largest 10 holders included Sofinnova Investments, Inc., FRAZIER MANAGEMENT LLC, New Leaf Venture Partners, L.L.C., Cormorant Asset Management, LP, FRANKLIN RESOURCES INC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, TIVERTON ASSET MANAGEMENT LLC, UBS OCONNOR LLC, Neuburgh Advisers LLC, and Flinton Capital Management LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.